Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Every row

Showing 6 of 382 rows for Dementia care management / navigation. One row per study per exposure: a study that tested two different things appears twice, once for each.

Scroll the table sideways to see every column.

Research and outcomes, 6 rows. Every row links to its source.
Exposure Question Direction Outcome measured Design People Effect size, as the source reported it Source
Dementia care management / navigation Care, carers and services Treatment Benefit
why

The community health worker programme achieved verified linkage to medical care in 16.7% of dyads versus none in the control arm. Caregiver outcomes were largely unchanged, with self-efficacy favouring control.

Clinic-verified linkage to medical services at 6 months (primary); caregiver psychosocial outcomes randomised trial 287 PLAN increased linkage to medical services versus control (16.7% vs 0%, chi-squared [df = 1] = 24.05, p < 0.001). Caregiver outcomes were largely unchanged, with self-efficacy favoring control Alzheimer's & dementia : the journal of the Alzheimer's Association 2026
✓ Peer-reviewed PMID 42233272
Dementia care management / navigation Care, carers and services Treatment No effect
why

No difference between health-system care, community-based care or usual care on either primary outcome. Caregiver self-efficacy did improve in both active arms.

NPI-Q behavioural symptoms and caregiver strain (co-primary) randomised trial 2,176 NPI-Q difference health-system vs community 0.30 (97.5% CI -0.18 to 0.78); caregiver self-efficacy vs usual care +0.70 (health system) and +0.85 (community), both significant JAMA 2025
✓ Peer-reviewed PMID 39878968
Dementia care management / navigation Care, carers and services Treatment Benefit
why

Direction is for the extended nursing role intervention: 74% fewer unmet needs and higher quality of life at six months, with a small QALY gain at about 1,425 EUR added cost; no effect on caregiver burden.

Unmet needs, quality of life, caregiver burden and cost per QALY at six months (advanced dementia care management by nurses in extended roles) randomised trial 417 PlwD receiving the intervention had 74% lower unmet needs (0.26, CI95%: 0.17 to 0.40, p < 0.001) and higher quality of life (0.04, CI95%: 0.01 to 0.07, p = 0.017) than controls. There was a gain in quality-adjusted life years (0.01, CI95%: -0.001 to 0.018) at slightly higher costs (1,425 EUR, CI95%: 638 to 2,211) Alzheimer's & Dementia 2025
✓ Peer-reviewed PMID 41143334
Dementia care management / navigation Care, carers and services Treatment Mixed
why

The two perspectives disagree: the digitally supported care management system dominated usual care for the public payer (lower costs, marginally more QALYs, 72-79% probability of cost-effectiveness) but cost €331,000 per QALY from a societal perspective (33-35% probability).

Caregiver QALYs, costs and incremental cost per QALY at six months, from public-payer and societal perspectives randomised trial 192 Caregivers in the intervention group gained QALYs (+0.004 [95% CI -0.003 to 0.012], P value = .225) and had lower costs from the public payer (-378€ [1926-1168], P value = .630), but higher costs from the societal perspective (+1324 [-3634 to 6284], P value = .599). The intervention dominated usual care from the payer perspective, whereas the incremental cost-effectiveness ratio was €331 000/QALY from a societal perspective Value in Health 2025
✓ Peer-reviewed PMID 39922302
Dementia care management / navigation Care, carers and services Treatment Benefit
why

Direction is for the Care Ecosystem programme: total cost of care was $475.80 per member per month lower than matched controls at 12 months, with fewer emergency, outpatient and professional visits.

Total cost of care per member per month at 12 months versus propensity-matched controls cohort study 242 Care Ecosystem participants had significantly lower total cost of care at 12 months, mean savings of $475.80 per member per month compared with controls American Journal of Managed Care 2024
✓ Peer-reviewed PMID 39146484
Dementia care management / navigation Care, carers and services Treatment Benefit
why

Direction is for collaborative dementia care management: fewer neuropsychiatric symptoms, lower caregiver burden, better mental health and 0.137 QALYs gained at no significant added cost (3186€ per QALY) over 36 months; no difference in antidementia drug use, overall quality of life or inappropriate medication.

Neuropsychiatric symptoms, caregiver burden, quality of life and cost per QALY at 36 months after 6 months of collaborative dementia care management randomised trial 428 Participants receiving CDCM showed significantly fewer behavioral and psychological symptoms (adjusted mean difference [AMD] in NPI score, -10.26 [95% CI, -16.95 to -3.58]; P = .003; Cohen d, -0.78 [95% CI, -1.09 to -0.46]) ... and lower caregiver burden (AMD in BIZA-D score, -0.59 [95% CI, -0.81 to -0.37]; P < .001; Cohen d, -0.71 [95% CI, -1.03 to -0.40]) ... The CDCM group gained QALYs (0.137 [95% CI, 0.000 to 0.274]; P = .049; Cohen d, 0.20 [95% CI, -0.09 to 0.40]) but had no significant increase in costs (437€ [-5438€ to 6313€] [US $476 (95% CI, -$5927 to $6881)]; P = .87; Cohen d, 0.07 [95% CI, -0.14 to 0.28]), resulting in a cost-effectiveness ratio of 3186€ (US $3472) per QALY JAMA Network Open 2024
✓ Peer-reviewed PMID 38967926

How this table was built, and where it is weak →

Last updated